On the same day that the PTAB instituted review of an AbbVie Biotechnology Ltd. (“AbbVie”) patent covering a method of using adalimumab...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
BiosimilarsIP.com News section provides updates on current news and events related to biologics and biosimilars.
-
-
At the urging of Sandoz Inc. (“Sandoz”), the PTAB instituted review of claims 1, 2, and 5-7 of U.S. Patent No. 9,067,992 (“the ʼ992...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Last week, Mylan N.V. and Biocon Ltd. announced that their jointly-developed insulin glargine biosimilar, Semglee™, received marketing...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Sandoz’s request for inter partes review (“IPR”) of U.S. Patent Numbers 9,512,216 (“the ’216 patent”) and 8,802,100 (“the...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Mumbai-based pharmaceutical manufacturer Lupin recently received FDA approval for its generic version of Roche’s Tamiflu® (oseltamivir...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
We previously reported that on January 11, 2018, Celltrion, Inc., Celltrion Healthcare, Co. Ltd. (collectively “Celltrion”), Teva...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
On January 11, 2018, Celltrion, Inc., Celltrion Healthcare, Co. Ltd. (collectively “Celltrion”), Teva Pharmaceuticals International...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]